The University of Chicago Header Logo

Connection

Marina Chiara Garassino to Azacitidine

Back to Details
This is a "connection" page, showing publications Marina Chiara Garassino has written about Azacitidine.
Marina Chiara Garassino
Connection Strength
0.040
Azacitidine
  1. Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer. Eur J Cancer. 2019 02; 108:120-128.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.